King Charles shares update on cancer treatment
Digest more
A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian cancer. The company plans to appeal the verdict.
A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch the disease.
Indoor tanning is trending among Gen Z. A new study finds tanning bed users not only have a much higher risk of melanoma, they also have DNA damage linked to cancer across nearly their entire skin.
3don MSN
At least 197 children were fathered by sperm donor with cancer-causing gene. Some have already died
A sperm donor with a rare genetic mutation linked to an increased risk of developing cancer fathered at least 197 children across Europe, some of whom have already died from the disease, according to a new investigation.
In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the cancer from recurring or possibly prevent it entirely.
Jason Collins, whose NBA career spanned 13 years and six different teams, announced on Thursday that he has Stage 4 brain cancer. Specifically Collins has glioblastoma, a common form of brain cancer that spreads aggressively and quickly.
This immunotherapy treatment holds promise beyond rectal cancer. In early studies of people with esophageal, bladder, or prostate tumors with the same molecular signature, 80 percent were cured. Sometimes the pain of a tumor subsides within days.
MedPage Today on MSN
For your patients: What to know about the newest treatments for HR+/HER2- breast cancer
The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway that promotes cancer cell division and inhibits it.